ICICI Lombard General Insurance allots shares worth Rs 2 lakh to employees as stock option

ICICI Lombard General Insurance allots shares worth Rs 2 lakh to employees as stock option

The company has assigned the shares worth Rs 2,46,500 under the ICICI Lombard Employees Stock Option Scheme-2005.

FPJ Web DeskUpdated: Wednesday, March 15, 2023, 12:51 PM IST
article-image
ICICI Lombard General Insurance allots shares worth Rs 2 lakh to employees as stock option | ICICI Lombard General Insurance

ICICI Lombard General Insurance on Wednesday allotted 24,650 equity shares worth Rs 10 each to employees as stock option, the company announced through an exchange filing. The company has assigned the shares worth Rs 2,46,500 under the ICICI Lombard Employees Stock Option Scheme-2005.

The equity shares shall rank pari-passu with the existing equity shares of the company.

ICICI Lombard General Insurance shares

The shares of ICICI Lombard General Insurance on Wednesday at 12:46 pm IST were at 1,070.95, down by 0.098 per cent.

ICICI Bank ESOP

ICICI Bank on March 14 allocated shares worth Rs 4 lakh to employees as stock options.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Crompton allots share worth Rs 1.45 lakh to employees as stock options

Crompton allots share worth Rs 1.45 lakh to employees as stock options

Nitin Gadkari says, ‘India's highway infrastructure will match US by 2024’: Report

Nitin Gadkari says, ‘India's highway infrastructure will match US by 2024’: Report

Elon Musk offers significant stock grants to Twitter employees after relentless layoffs: Report

Elon Musk offers significant stock grants to Twitter employees after relentless layoffs: Report

Ahead of share market: Factors to consider before trading begins next week

Ahead of share market: Factors to consider before trading begins next week

USFDA completes inspections of Lupin's operations

USFDA completes inspections of Lupin's operations